Neogen/$NEOG
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Neogen
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
Ticker
$NEOG
Sector
Primary listing
Employees
2,974
Headquarters
Website
Neogen Metrics
BasicAdvanced
$1.4B
-
-$4.81
1.90
-
Price and volume
Market cap
$1.4B
Beta
1.9
52-week high
$16.04
52-week low
$3.87
Average daily volume
5.2M
Financial strength
Current ratio
3.584
Quick ratio
1.897
Long term debt to equity
37.407
Total debt to equity
37.407
Interest coverage (TTM)
-0.26%
Profitability
EBITDA (TTM)
100.769
Gross margin (TTM)
46.39%
Net profit margin (TTM)
-117.61%
Operating margin (TTM)
-2.03%
Effective tax rate (TTM)
2.85%
Revenue per employee (TTM)
$300,000
Management effectiveness
Return on assets (TTM)
-0.28%
Return on equity (TTM)
-39.71%
Valuation
Price to revenue (TTM)
1.566
Price to book
0.66
Price to tangible book (TTM)
-4.13
Price to free cash flow (TTM)
-440.529
Free cash flow yield (TTM)
-0.23%
Free cash flow per share (TTM)
-0.015
Growth
Revenue change (TTM)
-2.78%
Earnings per share change (TTM)
4,268.36%
3-year revenue growth (CAGR)
18.63%
10-year revenue growth (CAGR)
11.81%
3-year earnings per share growth (CAGR)
142.24%
10-year earnings per share growth (CAGR)
30.27%
What the Analysts think about Neogen
Analyst ratings (Buy, Hold, Sell) for Neogen stock.
Bulls say / Bears say
Neogen’s management projects fiscal 2026 revenue between $820 million and $840 million, with adjusted EBITDA in the range of $165 million to $175 million, signaling confidence in a near-term recovery despite recent setbacks (Reuters)
After reporting Q1 FY 2026 earnings above expectations—$209.2 million in revenue versus a $203.1 million estimate—and reaffirming full-year guidance, Neogen shares jumped 6.4% in pre-market trading, signaling strong investor approval of its performance (Barron's)
The company has taken steps to improve efficiency, including targeted layoffs, which management believes will boost margins and allow for investments in its strategy (Barron's)
Neogen’s fourth-quarter revenue dropped 4.8% year-over-year to $225.5 million, showing continued weak demand in its end markets and uncertainty in trade, which pressured its top-line results (Reuters)
The company posted a $612.2 million net loss in Q4 FY 2025 due to a non-cash goodwill impairment related to the 3M Food Safety acquisition, underscoring challenges with integration and significant asset write-downs (Reuters)
Adjusted EPS for Q4 FY 2025 was $0.05, below analyst expectations of $0.07, highlighting continued pressure on profitability from higher costs and weaker sales volumes (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 3 Nov 2025.
Neogen Financial Performance
Revenues and expenses
Neogen Earnings Performance
Company profitability
Neogen News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Neogen stock?
Neogen (NEOG) has a market cap of $1.4B as of November 09, 2025.
What is the P/E ratio for Neogen stock?
The price to earnings (P/E) ratio for Neogen (NEOG) stock is 0 as of November 09, 2025.
Does Neogen stock pay dividends?
No, Neogen (NEOG) stock does not pay dividends to its shareholders as of November 09, 2025.
When is the next Neogen dividend payment date?
Neogen (NEOG) stock does not pay dividends to its shareholders.
What is the beta indicator for Neogen?
Neogen (NEOG) has a beta rating of 1.9. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.